{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:02Z","timestamp":1781049602818,"version":"3.54.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T00:00:00Z","timestamp":1736812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T00:00:00Z","timestamp":1736812800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1007\/s10067-025-07313-2","type":"journal-article","created":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T16:09:45Z","timestamp":1736870985000},"page":"1299-1305","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Hepatitis B vaccine and juvenile idiopathic arthritis: comparison of the seropositivity rates with healthy children at the time of diagnosis and booster dose response under treatment"],"prefix":"10.1007","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4584-1818","authenticated-orcid":false,"given":"Merve I\u015feri","family":"Nepesov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fc\u015fta Uysal","family":"G\u00fcr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rabia G\u00f6n\u00fcl Sezer","family":"Yamanel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa","family":"\u00c7akan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,14]]},"reference":[{"key":"7313_CR1","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s12969-021-00629-8","volume":"19","author":"LN Zaripova","year":"2021","unstructured":"Zaripova LN, Midgley A, Christmas SE, Beresford MW, Baildam EM, Oldershaw RA (2021) Juvenile idiopathic arthritis: from aetiopathogenesis to therapeutic approaches. Pediatr Rheumatol Online J 19:135. https:\/\/doi.org\/10.1186\/s12969-021-00629-8","journal-title":"Pediatr Rheumatol Online J"},{"key":"7313_CR2","doi-asserted-by":"publisher","unstructured":"Nagy A, M\u00e1trai P, Hegyi P, Alizadeh H, Bajor J, Czopf L, Gy\u00f6ngyi Z, Kiss Z, M\u00e1rta K, Simon M, Szil\u00e1gyi \u00c1L, Veres G, Mosd\u00f3si B (2019) The effects of TNF-alpha inhibitor therapy on the incidence of infection in JIA children: a meta-analysis. Pediatr Rheumatol Online J 17:4. https:\/\/doi.org\/10.1186\/s12969-019-0305-x","DOI":"10.1186\/s12969-019-0305-x"},{"key":"7313_CR3","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1007\/s10067-012-2082-5","volume":"2012","author":"T Imagawa","year":"2012","unstructured":"Imagawa T, Takei S, Umebayashi H, Yamaguchi K, Itoh Y, Kawai T, Iwata N, Murata T, Okafuji I, Miyoshi M, Onoe Y, Kawano Y, Kinjo N, Mori M, Mozaffarian N, Kupper H, Santra S, Patel G, Kawai S, Yokota S (2012) Efficacy, pharmacokinetics, and safety of adalimumab in pediatric patients with juvenile idiopathic arthritis in Japan. Clin Rheumatol 2012:1713\u20131721. https:\/\/doi.org\/10.1007\/s10067-012-2082-5","journal-title":"Clin Rheumatol"},{"key":"7313_CR4","doi-asserted-by":"publisher","unstructured":"Szczygielska I, Hernik E, Kwiatkowska M, Rutkowska-Sak L, Ko\u0142odziejczyk B, Gazda A (2015) Assessment of the level of vaccine-induced anti-HBs antibodies in children with inflammatory systemic connective tissue diseases treated with immunosuppression. Reumatologia 53:56\u201360. https:\/\/doi.org\/10.5114\/reum.2015.51503","DOI":"10.5114\/reum.2015.51503"},{"key":"7313_CR5","first-page":"164","volume":"38","author":"M Bizjak","year":"2020","unstructured":"Bizjak M, Blazina \u0160, Zajc Avramovi\u010d M, Markelj G, Av\u010din T, Toplak N (2020) Vaccination coverage in children with rheumatic diseases. Clin Exp Rheumatol 38:164\u2013170","journal-title":"Clin Exp Rheumatol"},{"key":"7313_CR6","doi-asserted-by":"publisher","unstructured":"Hsu YC, Huang DQ, Nguyen MH (2023) Global burden of hepatitis B virus: current status, missed opportunities and a call for action. Nat Rev Gastroenterol Hepatol 20:524\u2013537. https:\/\/doi.org\/10.1038\/s41575-023-00760-9","DOI":"10.1038\/s41575-023-00760-9"},{"key":"7313_CR7","unstructured":"Aaron Harris, CDC Yellow Book (2024) Hepatitis B, Travel-Associated Infections & Diseases, https:\/\/wwwnc.cdc.gov\/travel\/yellowbook\/2024\/infections-diseases\/hepatitis-b Accessed 2 April 2024"},{"key":"7313_CR8","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1016\/j.cmi.2015.06.028","volume":"21","author":"N Tozun","year":"2015","unstructured":"Tozun N, Ozdogan O, Cakaloglu Y, Idilman R, Karasu Z, Akarca U, Kaymakoglu S, Ergonul O (2015) Seroprevalence of hepatitis B and C virus infections and risk factors in Turkey: a fieldwork TURHEP study. Clin Microbiol Infect 21:1020\u20131026. https:\/\/doi.org\/10.1016\/j.cmi.2015.06.028","journal-title":"Clin Microbiol Infect"},{"key":"7313_CR9","unstructured":"Turkey\u2019s National Immunization Program. https:\/\/covid19asi.saglik.gov.tr\/EN-80229\/turkeys-national-immunization-program--.htmlAccessed 29 March 2024"},{"key":"7313_CR10","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1086\/589722","volume":"198","author":"K Cardell","year":"2008","unstructured":"Cardell K, Akerlind B, S\u00e4llberg M, Fryd\u00e9n A (2008) Excellent response rate to a double dose of the combined hepatitis A and B vaccine in previous nonresponders to hepatitis B vaccine. J Infect Dis 198:299\u2013304. https:\/\/doi.org\/10.1086\/589722","journal-title":"J Infect Dis"},{"key":"7313_CR11","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.anai.2018.03.017","volume":"121","author":"TV Saco","year":"2018","unstructured":"Saco TV, Strauss AT, Ledford DK (2018) Hepatitis B vaccine nonresponders: possible mechanisms and solutions. Ann Allergy Asthma Immunol 121:320\u2013327. https:\/\/doi.org\/10.1016\/j.anai.2018.03.017","journal-title":"Ann Allergy Asthma Immunol"},{"key":"7313_CR12","first-page":"390","volume":"31","author":"Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J, He X, Maldonado-Cocco J, Orozco-Alcala J, Prieur AM, Suarez-Almazor ME, Woo P; International League of Associations for Rheumatology","year":"2004","unstructured":"Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J, He X, Maldonado-Cocco J, Orozco-Alcala J, Prieur AM, Suarez-Almazor ME, Woo P; International League of Associations for Rheumatology (2004) International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 31:390\u2013392","journal-title":"J Rheumatol"},{"key":"7313_CR13","unstructured":"Hepatitis B vaccines: WHO position paper (2017) https:\/\/www.who.int\/publications\/i\/item\/WER9227Accessed 30 March 2024"},{"key":"7313_CR14","first-page":"969","volume":"31","author":"D Maritsi","year":"2013","unstructured":"Maritsi D, Vartzelis G, Soldatou A, Garoufi A, Spyridis N (2013) Markedly decreased antibody titers against hepatitis B in previously immunised children presenting with juvenile idiopathic arthritis. Clin Exp Rheumatol 31:969\u2013673","journal-title":"Clin Exp Rheumatol"},{"key":"7313_CR15","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1007\/s00296-021-04833-3","volume":"42","author":"F \u00c7akmak","year":"2022","unstructured":"\u00c7akmak F, \u00c7akan M, Demir F, Sonmez HE, \u00c7akmak S, Demirkan FG, Karada\u011f \u015eG, Ayaz NA, S\u00f6zeri B (2022) Hepatitis B vaccination response of treatment-naive patients with juvenile idiopathic arthritis. Rheumatol Int 42:1199\u20131205. https:\/\/doi.org\/10.1007\/s00296-021-04833-3","journal-title":"Rheumatol Int"},{"key":"7313_CR16","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s12969-021-00594-2","volume":"19","author":"MM Kostik","year":"2021","unstructured":"Kostik MM, Lubimova NA, Fridman IV, Goleva OV, Kharit SM (2021) The vaccine coverage and vaccine immunity status and risk factors of non-protective levels of antibodies against vaccines in children with juvenile idiopathic arthritis: cross-sectional Russian tertiary Centre study. Pediatr Rheumatol Online J 19:108. https:\/\/doi.org\/10.1186\/s12969-021-00594-2","journal-title":"Pediatr Rheumatol Online J"},{"key":"7313_CR17","first-page":"47","volume":"46","author":"A S\u00fcleyman","year":"2012","unstructured":"S\u00fcleyman A, G\u00f6k\u00e7ay G, Badur S, Ayk\u0131n S, K\u0131l\u0131\u00e7 G, Tamay Z, Un\u00fcvar E, G\u00fcler N (2012) Evaluation of serological status of children following hepatitis B vaccination during infancy. Mikrobiyol Bul 46:47\u201356","journal-title":"Mikrobiyol Bul"},{"key":"7313_CR18","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1007\/s00431-012-1815-4","volume":"171","author":"C Aypak","year":"2012","unstructured":"Aypak C, Y\u00fcce A, Y\u0131k\u0131lkan H, G\u00f6rpelio\u011flu S (2012) Persistence of protection of hepatitis B vaccine and response to booster immunization in 2- to 12-year-old children. Eur J Pediatr 171:1761\u20131766. https:\/\/doi.org\/10.1007\/s00431-012-1815-4","journal-title":"Eur J Pediatr"},{"key":"7313_CR19","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268823001747","volume":"151","author":"Y Chai","year":"2023","unstructured":"Chai Y, Tang J, Su Y, Xuan K, Xu L, Hao J, Lu Z, Wang B, Chen X, Luo X, He J, Zhu L (2023) Hepatitis B antibody levels after different doses of hepatitis B vaccination: a retrospective study based on hospitalized children. Epidemiol Infect 151:e186. https:\/\/doi.org\/10.1017\/S0950268823001747","journal-title":"Epidemiol Infect"},{"key":"7313_CR20","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/infdis\/jiv748","volume":"214","author":"MG Bruce","year":"2016","unstructured":"Bruce MG, Bruden D, Hurlburt D, Zanis C, Thompson G, Rea L, Toomey M, Townshend-Bulson L, Rudolph K, Bulkow L, Spradling PR, Baum R, Hennessy T, McMahon BJ (2016) Antibody levels and protection after hepatitis B vaccine: results of a 30-year follow-up study and response to a booster dose. J Infect Dis 214:16\u201322. https:\/\/doi.org\/10.1093\/infdis\/jiv748","journal-title":"J Infect Dis"},{"key":"7313_CR21","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1136\/annrheumdis-2022-222574","volume":"82","author":"MHA Jansen","year":"2023","unstructured":"Jansen MHA, Rondaan C, Legger GE, Minden K, Uziel Y, Toplak N, Maritsi D, van den Berg L, Berbers GAM, Bruijning P, Egert Y, Normand C, Bijl M, Foster HE, Kon\u00e9-Paut I, Wouters C, Ravelli A, Elkayam O, Wulffraat NM, Heijstek MW (2023) EULAR\/PRES recommendations for vaccination of paediatric patients with autoimmune inflammatory rheumatic diseases: update 2021. Ann Rheum Dis 82:35\u201347. https:\/\/doi.org\/10.1136\/annrheumdis-2022-222574","journal-title":"Ann Rheum Dis"},{"key":"7313_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2022.956136","volume":"10","author":"B Bala\u017eiov\u00e1","year":"2022","unstructured":"Bala\u017eiov\u00e1 B, Kukov\u00e1 Z, Mi\u0161\u00edkov\u00e1 D, Novosedl\u00edkov\u00e1 K, Dallos T (2022) Real-life vaccination coverage in Slovak children with rheumatic diseases. Front Pediatr 10:956136. https:\/\/doi.org\/10.3389\/fped.2022.956136","journal-title":"Front Pediatr"},{"key":"7313_CR23","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1136\/ard.2003.013201","volume":"63","author":"O Kasap\u00e7opur","year":"2004","unstructured":"Kasap\u00e7opur O, Cullu F, Kamburo\u011flu-Goksel A, Cam H, Akdenizli E, Cal\u00fdkan S, Sever L, Ar\u00fdsoy N (2004) Hepatitis B vaccination in children with juvenile idiopathic arthritis. Ann Rheum Dis 63:1128\u20131130. https:\/\/doi.org\/10.1136\/ard.2003.013201","journal-title":"Ann Rheum Dis"},{"key":"7313_CR24","doi-asserted-by":"publisher","first-page":"368","DOI":"10.3109\/14397595.2015.1085608","volume":"26","author":"Y Nerome","year":"2016","unstructured":"Nerome Y, Akaike H, Nonaka Y, Takezaki T, Kubota T, Yamato T, Yamasaki Y, Imanaka H, Kawano Y, Takei S (2016) The safety and effectiveness of HBV vaccination in patients with juvenile idiopathic arthritis controlled by treatment. Mod Rheumatol 26:368\u2013371. https:\/\/doi.org\/10.3109\/14397595.2015.1085608","journal-title":"Mod Rheumatol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-025-07313-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-025-07313-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-025-07313-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T08:19:42Z","timestamp":1740557982000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-025-07313-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,14]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["7313"],"URL":"https:\/\/doi.org\/10.1007\/s10067-025-07313-2","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,14]]},"assertion":[{"value":"10 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Approval for the study was obtained from the Local Ethical Committee (March 2024\u2014decision number: 28). The study was conducted according to Good Clinical Practice Guidelines and the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All authors participate in the conception or design of the work and analysis. Final approval of the version to be published is seen by all the authors and they all agree with the accuracy or integrity of the work by ICMJE 4 authorship criteria. All authors agreed to publish in Clinical Rheumatology. This work has not been published before or is not under consideration for publication anywhere else.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Informed consent was obtained from legal guardians.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"None.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}